ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,474,000 | -66.9% | 1,500,000 | -66.7% | 0.10% | -89.7% |
| Q1 2018 | $4,458,000 | +40.8% | 4,500,000 | +50.0% | 0.96% | +46.3% |
| Q4 2017 | $3,167,000 | -25.4% | 3,000,000 | -25.0% | 0.66% | -20.5% |
| Q3 2017 | $4,243,000 | -27.2% | 4,000,000 | -27.3% | 0.82% | +58.0% |
| Q2 2017 | $5,830,000 | -9.6% | 5,500,000 | -17.9% | 0.52% | -31.8% |
| Q1 2017 | $6,449,000 | +0.8% | 6,700,000 | +7.2% | 0.76% | +4.5% |
| Q4 2016 | $6,395,000 | -9.3% | 6,250,000 | -17.2% | 0.73% | -24.1% |
| Q3 2016 | $7,050,000 | +20.0% | 7,550,000 | -7.9% | 0.96% | -45.7% |
| Q2 2016 | $5,875,000 | -20.0% | 8,200,000 | +2.5% | 1.78% | +52.7% |
| Q1 2016 | $7,341,000 | -14.5% | 8,000,000 | +5.3% | 1.16% | -15.7% |
| Q4 2015 | $8,589,000 | – | 7,600,000 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alken Asset Management Ltd | 850,000 | $848,000 | 3.53% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 34,448,000 | $35,346,000 | 1.72% |
| Sonora Investment Management, LLC | 9,376,000 | $9,408,000 | 1.12% |
| CSS LLC/IL | 7,500,000 | $7,639,000 | 0.60% |
| IRON Financial LLC | 490,000 | $498,000 | 0.31% |
| MACKAY SHIELDS LLC | 32,910,000 | $33,383,000 | 0.31% |
| RWC Asset Management LLP | 4,550,000 | $4,642,000 | 0.24% |
| Opti Capital Management, LP | 1,000 | $1,024,000 | 0.21% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $4,956,000 | 0.18% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,283,000 | $5,301,000 | 0.12% |